In this study, we examined phosphoinositide metabolism during ischemia and reperfusion using an isolated and perfused rat heart. When myocardial phosphoinositides were prelabeled with These studies have suggested that phospholipase A 2 activity is stimulated during reperfusion, presumably due to massive Ca 2+ influx into the cardiac cell.
R ecent studies have demonstrated that reperfusion of ischemic myocardium enhances membrane phospholipid degradation. 1 -3 These studies have suggested that phospholipase A 2 activity is stimulated during reperfusion, presumably due to massive Ca 2+ influx into the cardiac cell. 4 It is also known that phosphatidylinositol (Pl)-specific phospholipase C activity is enhanced by various humoral and hormonal stimulations in numerous mammalian cells. 3 -6 Stimulation of Pi-specific phospholipase C activity, thus, results in the generation of inositol trisphosphate (IP 3 ) and diacylglycerol, which are novel intracellular messengers mediating Ca 2+ -dependent phys-iological responses in biological systems. 7 We have recently documented that the phosphodiesteratic breakdown of phosphatidylinositol-4,5-bisphosphate (PI-4,5-p2) occurs in the rat left ventricular papillary muscle by a,-adrenoceptor stimulation, by addition of prostaglandin F^, or by Ca 2+ overload. 8 - 10 Since myocardial ischemia and reperfusion are known to increase a,-adrenergic receptors" and prostaglandin synthesis 3 as well as Ca 2+ influx, 12 it may be speculated that ischemia and postischemic reperfusion may potentiate the phosphoinositide breakdown in the heart. The results of our present study indicate that reperfusion of ischemic myocardium stimulates phosphodiesteratic breakdown of phosphoinositides, and also increases turnover of these phospholipids.
Materials and Methods
Male Sprague-Dawley rats weighing 250-300 g were anesthetized with intravenous injection of sodium pentobarbital. The hearts were removed and perfused with Krebs-Henseleit bicarbonate (KHB) buffer equilibrated with a gas mixture of 95% O 2 -5% CO 2 , pH of 7.4, using LangendorfTs -free KHB buffer, CaCl 2 was omitted. Coronary perfusion pressure and perfusate temperature were maintained at 100 g H 2 O and at 37° C, respectively. After 10 minutes of preperfusion, the heart was perfused with a fresh 50 ml KHB buffer containing 20 /iCi of myo[2-
arachidonic acid (New England Nuclear, Boston, Massachusetts) for 45 minutes, followed by perfusion with another nonrecirculating KHB buffer containing 10 mM LiCI to inhibit inositol phosphate phosphatase. 13 Ten minutes after the final perfusion, the retrograde aortic flow was terminated and the heart was made globally ischemic for 30 minutes in physiological saline solution at 37° C. Reperfusion was performed for 30 minutes following 30 minutes of ischemia with nonrecirculating KHB buffer containing 10 mM LiCI. The control heart was perfused with nonrecirculating KHB containing 10 mM LiCI for 60 minutes instead of 30 minutes of ischemia followed by 30 minutes of reperfusion.
To investigate the effect of reperfusion on turnover of phosphoinositides, the heart was made ischemic for 30 minutes and was reperfused for 30 minutes with 50 ml of recirculating KHB buffer containing 20 /iCi [ 3 H]inositol or 50 /tCi [2-New York) and centrifuged at 8,00% for 10 minutes. The supernatant was neutralized with 5 M K 2 CO 3 , and the precipitate was removed by centrifugation at l,000g for 5 minutes. The supernatant was applied to anion exchange column chromatography as described previously. 8 The 1.0 ml fractions eluted from the column were counted in duplicate for radioactivity.
Myocardial lipids were extracted with chloroformmethanol mixture by the method of Folch et al, 14 except that phosphoinositides were extracted with acidified chloroform-methanol mixture. 13 Neutral lipids were separated on silica gel GF plates (Analtech Inc., Newark, Delaware) using a mixture of hexane-diethylether-acetic acid (70:30:1, vol/vol/ vol) as a developing solvent. 16 Phosphatidic acid was separated on silica K6 plates (Whatman Inc., Clifton, New Jersey) using chloroform-methanolpetroleum ether-acetic acid boric acid (40:20: 30:10:1.8, vol/vol/vol/vol/wt) as a developing solvent. 17 Phosphoinositides were separated on potassium oxalate (1%) impregnated silica gel H plates using chloroform-methanol-acetone-acetic acid-water (40:13:15:12:8, vol/vol/vol/vol/vol) as a developing solvent. 18 The lipids on the silica gel plates were identified by cochromatography with authentic lipid standards after brief exposure with iodine vapor, scraped off into scintillation vials, and counted in duplicate for radioactivity. PI was quantitated by the method of Bartlett. 19 Prazosin was used as an a,-adrenoceptor antagonist and was a gift from Pfizer Inc., New York, New York. Atropine, indomethacin, superoxide dismutase (bovine blood), catalase (bovine liver), and mepacrine were obtained from Sigma Chemical Co., St. Louis, Missouri. Student's / test was used for statistical analysis.
Results
We first measured the change in the level of phosphoinositide contents and [ (Table 1) . Phosphatidylinositol-4-phosphate (PI-4-P) and phosphatidylinositol-4,5-bisphosphate (PI-4,5-P 2 ) contents were undetectable by the phosphorous assay method described by Bartlett. 19 PI contents, however, remained unchanged during 30 minutes of a. 5.
[ ischemia, but decreased slightly during reperfusion compared with 60 minutes of control perfusion (7.3±0.82 vs. 6.3±0.49, Aimol/g dry wt, difference not significant). Radioactivity in PI remained unchanged, but that in PI-4-P and PI-4,5-P 2 decreased significantly during 30 minutes of ischemia. There was no significant difference in the level of any of [ 3 H]phosphoinositides between nonischemic-perfused and ischemic-reperfused hearts.
We next examined the effect of ischemia and reperfusion on the accumulations of radiolabeled IP 3 , IP 2 , and IP in the heart prelabeled with [ H]glycerol into PI in the ischemicreperfused heart was also less than that in the nonischemic-perfused heart, but the difference did not reach statistical significance (p>0.05).
In the heart prelabeled with [ l4 C]arachidonic acid, isotopic incorporation into diacylglycerol, phosphatidic acid, PI-4-P, and PI-4,5-P 2 decreased during ischemia ( Table 4 ). The isotopic incorporation into PI remained unchanged during ischemia and reperfusion. The isotopic incorporation into diacylglycerol and phosphatidic acid, however, increased during reperfusion significantly compared with the nonischemic-perfused heart, and that into PI-4-P and PI-4,5-P 2 returned to the preischemic level during reperfusion.
We tested the effects of various treatments on the reperfusion-induced increase in accumulations of IPs. Finally, we tested the effect of mepacrine on the phosphoinositide breakdown, because mepacrine is known to inhibit Pi-specific phospholipase C as well as phospholipase A 2 activity. 20 When mepacrine at a concentration of 50 /AM was added to the reperfusate, the accumulation of [ 
Discussion
This paper is the first to describe the effects of ischemia and of postischemic reperfusion on phosphoinositide metabolism in the heart. The present study demonstrates that myocardial reperfusion after 30 minutes of ischemia stimulates phosphodiesteratic breakdown and turnover of phosphoinositides. The pattern of [ 3 H]IP accumulations seems to indicate that Pi-specific phospholipase C primarily attacks PI-4,5-P 2 , resulting in the generation of IP 3 which may then be converted to IP 2 and to IP by respective phosphatases. However, it has become increasingly clear that a biologically active inositol 1,4,5-triphosphate isomer generated through receptor-linked hydrolysis of PI-4,5-P 2 can also be phosphorylated to inositol 1,3,4,5-tetrakisphosphate and then metabolized to a relatively inactive 1,3,4-triphosphate isomer to inositol 1,4-bisphosphate and to inositol-4-phosphate or inositol 1-phosphate. 21 Moreover, it has been proposed that in some mammalian cells, an accumulation of inositol-4-phosphate represents the hydrolysis of phosphoinositides, 22 whereas inositol monophosphate is perhaps the product of direct hydrolysis of PI. 23 Recently, Woodcock et al 24 demonstrated significant accumulations of [ 3 H]IPs in response to a,-adrenoceptor stimulation in the isolated and perfused rat heart. Inositol 1,3,4-triphosphate isomer was not detected in this study. The present study, however, does not address this issue. To draw unequivocal conclusions concerning the metabolic pathways of inositol lipids and inositol phosphates in the ischemic-reperfused heart, the nature of the predominant isomers of IPs has to be identified.
The enhanced phosphoinositide breakdown is associated with increased isotopic incorporation of In spite of the pulse-chase conditions used in our experiments for the evaluation of phosphoinositide breakdown and the relatively large increases in Caution must be exercised in interpreting this result because of the lack of knowledge concerning the changes of polyphosphoinositides biomass, as well as the possible heterogeneity of the inositol lipid pools in which only a fraction of the pools may become labeled for the relatively short period of radiolabeling with [ 3 H]inositol. Nevertheless, the enhanced turnover of phosphoinositides via the diacylglycerol-PI pathway observed in the ischemicreperfused heart suggests that the rat heart has an efficient mechanism for the resynthesis of phosphoinositides for continued phospholipase C-catalyzed hydrolysis of these phospholipids during reperfusion. It is also reasonable to assume that the net small loss of PI during reperfusion is not caused by phosphodiesteratic breakdown of PI, but is perhaps due to phospholipase Aj-catalyzed degradation as has been suggested previously. 1 -3 Thirty-minute ischemia caused no significant accumulations of [ 3 H]IPs. It seems likely that Pi-specific phospholipase C activity is not stimulated during ischemia, because the level of [ -free reperfusion with EGTA. It is, however, unknown whether increased intracellular Ca 2+ is a principal mediator or a cofactor of activation of Pi-specific phospholipase C.
We also tested the effect of mepacrine on the phosphoinositide breakdown. The concentration of mepacrine used in the present study (i.e., 50 /xM) represents a near IDJO against Pi-specific phospholipase C as well as phospholipase A 2 activity in vitro. 20 -27 Furthermore, this concentration of mepacrine was found to be effective in preventing membrane phospholipid degradation as well as myocardial injury during reperfusion in the isolated in situ pig heart model. The pathophysiology of enhanced phosphoinositide breakdown in the ischemic-reperfused rat heart is unknown. The studies using skinned cardiac fibers or isolated cardiac sarcoplasmic reticulum have shown that inositol 1,4,5-triphosphate mobilizes Ca 2+ from nonmitochondrial intracellular compartments. 28 -30 Moreover, our recent study 8 suggested that diacylglycerol may potentiate slow Ca channels through the activation of protein kinase C. It is, therefore, conceivable that the enhanced formation of IP 3 and diacylglycerol may act to increase intracellular Ca 2+ in cardiac myocytes. It is also intriguing to hypothesize that electrophysiological derangements often seen during reperfusion may be induced by such altered transmembrane Ca 2+ movements. However, the ventricular tissue used in our study contained a mixed population of cells. It is possible that the inositol lipids of vascular smooth muscles or endothelial cells also underwent enhanced metabolism during reperfusion. If this is the case, the reperfusioninduced increase in phosphoinositol breakdown would be involved in the regulation of coronary vascular tones. Future studies should focus on the role of enhanced phosphoinositide metabolism in modifying cardiac function during postischemic reperfusion.
